MW 294.4 Da, Purity >98%. Cell-permeable. Inhibits activation of SREBP (Sterol regulatory binding protein) transcription factors. Blocks lipid biosynthesis and accumulation. Active in vivo.
MW 294.4 Da, Purity >98%. Cell-permeable. Inhibits activation of SREBP (Sterol regulatory binding protein) transcription factors. Blocks lipid biosynthesis and accumulation. Active in vivo.
Soluble in DMSO to 75 mM.
Cell-permeable. Inhibits activation of SREBP (Sterol regulatory binding protein) transcription factors. Blocks lipid biosynthesis and accumulation. Active in vivo.
This product is manufactured by BioVision, an Abcam company and was previously called 2035 Fatostatin. 2035-25 is the same size as the 25 mg size of ab141490.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab141490, Fatostatin, SREBP (Sterol regulatory binding protein) transcription factors activation.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com